Correlation Between Spyre Therapeutics and QVC
Can any of the company-specific risk be diversified away by investing in both Spyre Therapeutics and QVC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spyre Therapeutics and QVC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spyre Therapeutics and QVC Group, you can compare the effects of market volatilities on Spyre Therapeutics and QVC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spyre Therapeutics with a short position of QVC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spyre Therapeutics and QVC.
Diversification Opportunities for Spyre Therapeutics and QVC
0.06 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Spyre and QVC is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and QVC Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on QVC Group and Spyre Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spyre Therapeutics are associated (or correlated) with QVC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of QVC Group has no effect on the direction of Spyre Therapeutics i.e., Spyre Therapeutics and QVC go up and down completely randomly.
Pair Corralation between Spyre Therapeutics and QVC
Given the investment horizon of 90 days Spyre Therapeutics is expected to generate 4.95 times less return on investment than QVC. But when comparing it to its historical volatility, Spyre Therapeutics is 2.21 times less risky than QVC. It trades about 0.05 of its potential returns per unit of risk. QVC Group is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 468.00 in QVC Group on June 1, 2025 and sell it today you would earn a total of 211.00 from holding QVC Group or generate 45.09% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Spyre Therapeutics vs. QVC Group
Performance |
| Timeline |
| Spyre Therapeutics |
| QVC Group |
Spyre Therapeutics and QVC Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Spyre Therapeutics and QVC
The main advantage of trading using opposite Spyre Therapeutics and QVC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spyre Therapeutics position performs unexpectedly, QVC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in QVC will offset losses from the drop in QVC's long position.| Spyre Therapeutics vs. Marine Products | Spyre Therapeutics vs. Mesa Air Group | Spyre Therapeutics vs. Ferrari NV | Spyre Therapeutics vs. Wabash National |
| QVC vs. Nasdaq Inc | QVC vs. Insteel Industries | QVC vs. Black Hawk Acquisition | QVC vs. MGIC Investment Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |